Table 1. Comprehensive demographic information of the patients.
| TCGA | GSE108474 | GTEx | |||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 2 | 1 | 2 | |||
| Gender | Gender | ||||||
| Male | 368 | 52.42 | 221 | 32.94 | Male | 792 | 68.75 |
| Female | 268 | 38.18 | 126 | 18.78 | Female | 360 | 31.25 |
| Age (years) | Body site | ||||||
| ≤65 | 549 | 78.21 | Amygdala | 69 | 5.99 | ||
| >65 | 87 | 12.39 | Anterior cingulate | 83 | 7.20 | ||
| WHO grade | Basal ganglia | 294 | 25.52 | ||||
| Non-tumor | 5 | 0.71 | 21 | 3.13 | Cerebellum | 216 | 18.75 |
| Grade I | 2 | 0.30 | Cortex | 207 | 17.97 | ||
| Grade II | 221 | 31.48 | 99 | 14.75 | Hippocampus | 84 | 7.29 |
| Grade III | 244 | 34.76 | 84 | 12.52 | Spinal cord | 82 | 7.12 |
| Grade IV | 166 | 16.52 | 134 | 19.97 | Substantia nigra | 60 | 5.21 |
| Survival status | |||||||
| Alive | 432 | 61.54 | 82 | 12.22 | |||
| Deceased | 204 | 29.06 | 313 | 46.65 | |||
WHO = World Health Organization. 1 = Patient characteristics, 2 = No. patients (%). Blank space indicates that the corresponding database has no relevant information.